Study ID: IXR-202-22-188

Study Title

Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors

Teva Identifier

IXR-202-22-188

ClinicalTrials.gov Identifier

NCT00104091

Study Status

Completed

Trial Condition(s)

Glioblastoma Multiforme

Interventions

Drug: TP-38

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria
cancer icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years and older

Trial Duration

12/01/2004 - 06/01/2007

Phase

Phase 2

Study Type

Interventional